Patrick Papart

635 total citations
34 papers, 487 citations indexed

About

Patrick Papart is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Experimental and Cognitive Psychology. According to data from OpenAlex, Patrick Papart has authored 34 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Experimental and Cognitive Psychology. Recurrent topics in Patrick Papart's work include Neurotransmitter Receptor Influence on Behavior (9 papers), Treatment of Major Depression (9 papers) and Stress Responses and Cortisol (6 papers). Patrick Papart is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (9 papers), Treatment of Major Depression (9 papers) and Stress Responses and Cortisol (6 papers). Patrick Papart collaborates with scholars based in Belgium, Netherlands and France. Patrick Papart's co-authors include Marc Ansseau, R. von Frenckell, M. Ansseau, Georges Franck, M Timsit-Berthier, Jean‐Jacques Legros, William Pitchot, Vincent Geenen, Michel Hansenne and A. González Moreno and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

Patrick Papart

31 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Papart Belgium 14 138 124 117 116 99 34 487
Ulrike Moser Austria 13 113 0.8× 185 1.5× 118 1.0× 89 0.8× 191 1.9× 28 637
A. Ariav Albala United States 10 140 1.0× 78 0.6× 125 1.1× 173 1.5× 74 0.7× 15 585
George N.M. Gurguis United States 15 64 0.5× 133 1.1× 144 1.2× 109 0.9× 59 0.6× 34 559
A F Schatzberg United States 12 176 1.3× 75 0.6× 146 1.2× 285 2.5× 99 1.0× 15 625
Olrik von Widdern Germany 8 106 0.8× 127 1.0× 65 0.6× 99 0.9× 128 1.3× 11 568
Anthony J. Rothschild United States 9 141 1.0× 89 0.7× 43 0.4× 170 1.5× 79 0.8× 14 467
Judith Haffmans Netherlands 14 170 1.2× 224 1.8× 79 0.7× 228 2.0× 44 0.4× 33 695
Isabel Martínez‐Gras Spain 15 132 1.0× 175 1.4× 128 1.1× 277 2.4× 146 1.5× 35 725
Martin Metten Germany 7 105 0.8× 123 1.0× 68 0.6× 96 0.8× 137 1.4× 7 571
Stephen M. Stahl United States 8 93 0.7× 81 0.7× 66 0.6× 135 1.2× 41 0.4× 16 416

Countries citing papers authored by Patrick Papart

Since Specialization
Citations

This map shows the geographic impact of Patrick Papart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Papart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Papart more than expected).

Fields of papers citing papers by Patrick Papart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Papart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Papart. The network helps show where Patrick Papart may publish in the future.

Co-authorship network of co-authors of Patrick Papart

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Papart. A scholar is included among the top collaborators of Patrick Papart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Papart. Patrick Papart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hansenne, Michel, William Pitchot, Emmanuel Pinto, Patrick Papart, & M. Ansseau. (2000). Serotonergic-1a activity and contingent negative variation. Biological Psychology. 52(3). 259–265. 9 indexed citations
2.
Hansenne, Michel, William Pitchot, Patrick Papart, & Marc Ansseau. (1998). Serotonergic modulation of P300. Human Psychopharmacology Clinical and Experimental. 13. 5 indexed citations
3.
Hansenne, Michel, William Pitchot, Patrick Papart, & Marc Ansseau. (1998). Serotonergic modulation of the P300 event related brain potential. Human Psychopharmacology Clinical and Experimental. 13(4). 239–243. 13 indexed citations
4.
Papart, Patrick, Marc Ansseau, & M Timsit-Berthier. (1996). CNV in mood disorders. Open Repository and Bibliography (University of Liège). 5 indexed citations
5.
Hansenne, Michel, William Pitchot, A. González Moreno, et al.. (1995). Catecholaminergic function and P300 amplitude in major depressive disorder (P300 and catecholamines). Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section. 96(2). 194–196. 37 indexed citations
6.
Pitchot, William, M. Ansseau, A. González Moreno, et al.. (1995). The Flesinoxan 5-HT1A Receptor Challenge in Major Depression and Suicidal Behavior. Pharmacopsychiatry. 28(S 2). 91–92. 20 indexed citations
7.
Ansseau, M., Patrick Papart, Michel Bataille, et al.. (1994). Controlled comparison of milnacipran and fluoxetine in major depression. Psychopharmacology. 114(1). 131–137. 42 indexed citations
8.
Schittecatte, Michel, G Charles, F. Dumont, et al.. (1994). Effects of gender and diagnosis on growth hormone response to clonidine for major depression: a large-scale multicenter study. American Journal of Psychiatry. 151(2). 216–220. 11 indexed citations
9.
Ansseau, Marc, William Pitchot, A. González Moreno, J. Wauthy, & Patrick Papart. (1993). Pilot study of flesinoxan, a 5‐HT1A agonist, in major depression: Effects on sleep REM latency and body temperature. Human Psychopharmacology Clinical and Experimental. 8(4). 279–283. 18 indexed citations
10.
Schittecatte, Michel, et al.. (1992). Growth hormone response to clonidine in male patients with panic disorder untreated by antidepressants. Psychological Medicine. 22(4). 1059–1062. 6 indexed citations
11.
Ansseau, Marc, et al.. (1991). Pilot study of flesinoxan, a 5-HT1A agonist, in major depression. Open Repository and Bibliography (University of Liège).
12.
Ansseau, M., et al.. (1991). Compulsive personality as predictor of response to serotoninergic antidepressants.. BMJ. 303(6805). 760–761. 28 indexed citations
14.
Pitchot, William, et al.. (1991). Pilot study of flesinoxan, a 5-HT1A agonist, in major depression. European Neuropsychopharmacology. 1(3). 436–436.
15.
Papart, Patrick, et al.. (1990). Contingent negative variation and severity of depression. Open Repository and Bibliography (University of Liège). 3 indexed citations
16.
Ansseau, M., et al.. (1990). Controlled Comparison of Buspirone and Oxazepam in Generalized Anxiety. Neuropsychobiology. 24(2). 74–78. 19 indexed citations
17.
Ansseau, M., R. von Frenckell, Patrick Papart, et al.. (1988). Blunted Response of Growth Hormone to Clonidine and Apomorphine in Endogenous Depression. The British Journal of Psychiatry. 153(1). 65–71. 60 indexed citations
18.
Ansseau, Marc, R. von Frenckell, Patrick Papart, et al.. (1987). Neuroendocrine evaluation of catecholaminergic neurotransmission in mania. Psychiatry Research. 22(3). 193–206. 18 indexed citations
19.
Ansseau, Marc, et al.. (1987). Intranasal oxytocin in obsessive-compulsive disorder. Psychoneuroendocrinology. 12(3). 231–236. 66 indexed citations
20.
Demey-Ponsart, Emilie, Marc Ansseau, J. Sulon, et al.. (1987). Diagnostic performance of basal free cortisol/18-hydroxy-11-deoxycorticosterone (18-OH-DOC) ratio in endogenous depression: Comparison with the dexamethasone suppression test. Biological Psychiatry. 22(8). 947–956. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026